Sionna Therapeutics (SION) Depreciation & Amortization (CF) (2024 - 2026)
Sionna Therapeutics' (SION) quarterly Depreciation & Amortization (CF) came in at $154000.0 in Q1 2026, down 23.0% year-on-year from $200000.0 in Q1 2025, and up 1.32% quarter-over-quarter from $152000.0 in Q4 2025.
Sionna Therapeutics (SION) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed Depreciation & Amortization (CF) across 3 years of filings, most recently posting $154000.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $154000.0, down 23.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $506000.0 (down 36.67% YoY), and the FY2025 annual result was $647000.0, down 7.57% from the prior year.
- Depreciation & Amortization (CF) came in at $154000.0 for Q1 2026 at Sionna Therapeutics, up from $152000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $200000.0 in Q1 2024 to a low of $100000.0 in Q2 2025.
- The 3-year median for Depreciation & Amortization (CF) is $199000.0 (2024), against an average of $167222.2.
- Peak annual rise in Depreciation & Amortization (CF) reached 0.0% in 2025, while the deepest fall reached 50.0% in 2025.
- Sionna Therapeutics' Depreciation & Amortization (CF) stood at $199000.0 in 2024, then slipped by 23.62% to $152000.0 in 2025, then increased by 1.32% to $154000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $154000.0 (Q1 2026), $152000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 429,663.65 |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154,000.00 |
| Mar 31, 2026 | 154,000.00 |
| Dec 31, 2025 | 152,000.00 |
| Dec 31, 2025 | 152,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 199,000.00 |
| Dec 31, 2024 | 199,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |